Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body Site

Joanna C. Fowler(Wellcome Sanger Institute), Charlotte King(Wellcome Sanger Institute), Chris Bryant(Wellcome Sanger Institute), Michael W.J. Hall(Wellcome Sanger Institute), Roshan Sood(Wellcome Sanger Institute), Swee Hoe Ong(Wellcome Sanger Institute), Eleanor Earp(Wellcome Sanger Institute), David Fernández‐Antorán(Wellcome Sanger Institute), Jonas Koeppel(Wellcome Sanger Institute), Stefan C. Dentro(European Bioinformatics Institute), David Shorthouse(Hutchison/MRC Research Centre), Amer Durrani(Cambridge University Hospitals NHS Foundation Trust), Kate Fife(Cambridge University Hospitals NHS Foundation Trust), Edward Rytina(Cambridge University Hospitals NHS Foundation Trust), Doreen Milne(Cambridge University Hospitals NHS Foundation Trust), Amit Roshan(Cambridge University Hospitals NHS Foundation Trust), Krishnaa Mahububani(National Institute for Health and Care Research), Kourosh Saeb‐Parsy(National Institute for Health and Care Research), Benjamin A. Hall(University College London), Moritz Gerstung(European Bioinformatics Institute), Philip H. Jones(Wellcome Sanger Institute)
Cancer Discovery
October 21, 2020
Cited by 101Open Access
Full Text

Abstract

Abstract Skin cancer risk varies substantially across the body, yet how this relates to the mutations found in normal skin is unknown. Here we mapped mutant clones in skin from high- and low-risk sites. The density of mutations varied by location. The prevalence of NOTCH1 and FAT1 mutations in forearm, trunk, and leg skin was similar to that in keratinocyte cancers. Most mutations were caused by ultraviolet light, but mutational signature analysis suggested differences in DNA-repair processes between sites. Eleven mutant genes were under positive selection, with TP53 preferentially selected in the head and FAT1 in the leg. Fine-scale mapping revealed 10% of clones had copy-number alterations. Analysis of hair follicles showed mutations in the upper follicle resembled adjacent skin, but the lower follicle was sparsely mutated. Normal skin is a dense patchwork of mutant clones arising from competitive selection that varies by location. Significance: Mapping mutant clones across the body reveals normal skin is a dense patchwork of mutant cells. The variation in cancer risk between sites substantially exceeds that in mutant clone density. More generally, mutant genes cannot be assigned as cancer drivers until their prevalence in normal tissue is known. See related commentary by De Dominici and DeGregori, p. 227. This article is highlighted in the In This Issue feature, p. 211


Related Papers

No related papers found

Powered by citation graph analysis